Dataset Information


CYC31, A Natural Bromophenol PTP1B Inhibitor, Activates Insulin Signaling and Improves Long Chain-Fatty Acid Oxidation in C2C12 Myotubes.

ABSTRACT: 3-bromo-4,5-Bis(2,3-dibromo-4,5-dihydroxybenzyl)-1,2-benzenediol (CYC31) is a bromophenol protein tyrosine phosphatase 1B (PTP1B) inhibitor isolated from the red alga Rhodomela confervoides. Here, the effect of CYC31 on the insulin signaling and fatty-acid-induced disorders in C2C12 myotubes was investigated. Molecular docking assay showed that CYC31 was embedded into the catalytic pocket of PTP1B. A cellular study found that CYC31 increased the activity of insulin signaling and promoted 2-NBDG uptake through GLUT4 translocation in C2C12 myotubes. Further studies showed that CYC31 ameliorated palmitate-induced insulin resistance in C2C12 myotubes. Moreover, CYC31 treatment significantly increased the mRNA expression of carnitine palmitoyltransferase 1B (CPT-1B) and fatty acid binding protein 3 (FABP3), which was tightly linked with fatty acid oxidation. These findings suggested that CYC31 could prevent palmitate-induce insulin resistance and could improve fatty acid oxidation through PTP1B inhibition.


PROVIDER: S-EPMC7281472 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC5740242 | BioStudies
1000-01-01 | S-EPMC4039661 | BioStudies
2015-01-01 | S-EPMC4439476 | BioStudies
2012-01-01 | S-EPMC3475448 | BioStudies
2007-11-15 | E-GEOD-6766 | ArrayExpress
2020-01-01 | S-EPMC7587383 | BioStudies
1000-01-01 | S-EPMC4285541 | BioStudies
2018-01-01 | S-EPMC6232724 | BioStudies
1000-01-01 | S-EPMC2978610 | BioStudies
2016-01-01 | S-EPMC4882499 | BioStudies